Regeneron Pharmaceuticals, Inc 10-K for FY2022
Regeneron Pharmaceuticals, Inc. (REGN)
10-K
2023-02-06
For: 2022-12-31
View Original
Added on
April 08, 2026
About this 10-K
Regeneron Pharmaceuticals, Inc filed this 10-K on February 6, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $12.17B
- down 24.3% from $16.07B a year earlier
- Net income
- $4.34B
- down 46.3% from net income of $8.08B a year earlier
- Diluted EPS
- $38.22
- down 46.9% from $71.97 a year earlier